Research finds that so-called “skinny labeling” which allows drug makers to sell generics for off-patent use saved Medicare around $1.5 billion, but a legal fight could upend the practice. The Center for Medicare and Medicaid Services new Direct Contracting Model saved the agency $70 million during its inaugural year. And CMS is warning hospital systems to do more to protect staff and patients. That's coming up on today's episode of Gist Healthcare Daily.
","author_name":"Gist Healthcare Daily"}